Company intelligence / Profile preview

Sanguine Biosciences

Woburn, Massachusetts, United Statessanguinebio.com ↗

Ownership: Private
Employees: ~98
Development stage: Commercial

Overview

Sanguine Biosciences accelerates translational biomedical research by providing ethically sourced human biospecimens with rich clinical annotation to researchers worldwide. Their direct-to-donor model enables access to rare patient populations and complex study designs. They have supported over 2,000 studies for more than 100 diagnosed conditions with high delivery reliability.

Therapeutic areas: CardiovascularOncologyMetabolic DisordersImmunologyHematologyRare DiseasesNeurologyInfectious Diseases
Modalities: Cell therapyGene therapy
Industry: Drug Discovery Services

Partnerships

Supported translational and clinical research at 20 of the top 40 global pharmaceutical and biotechnology companiesHepatitis B Foundation

Beyond the preview

Go deeper on Sanguine Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanguine Biosciences.

Explore the full profile